Measurement and Validation of the Comprehensive Score for Financial Toxicity (COST) in a Population With Diabetes.

Minal R PatelGuanghao ZhangMichele HeislerPeter X K SongJohn D PietteXu ShiHae Mi ChoeAlyssa SmithKenneth Resnicow

Published in: Diabetes care (2022)

Findings support both the reliability and validity of the COST-FACIT tool among adults with diabetes and high A1C levels. More research is needed to support the use of the COST-FACIT tool as a clinically relevant patient-centered instrument for diabetes care.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
oxidative stress
metabolic syndrome
adipose tissue
young adults
insulin resistance
skeletal muscle
health insurance